Document is current
Any future updates will be listed below
-
Authors
Singer, Susanne https://orcid.org/0000-0001-5784-7964
Hammerlid, Eva https://orcid.org/0000-0002-1813-108X
Tomaszewska, Iwona M. https://orcid.org/0000-0002-4118-5596
Amdal, Cecilie Delphin https://orcid.org/0000-0001-8422-8085
Bjordal, Kristin https://orcid.org/0000-0002-1914-494X
Herlofson, Bente Brokstad https://orcid.org/0000-0002-9621-9263
Santos, Marcos https://orcid.org/0000-0002-7055-4397
Silva, Joaquim Castro https://orcid.org/0000-0002-3934-9950
Mehanna, Hisham https://orcid.org/0000-0002-5544-6224
Fullerton, Amy https://orcid.org/0000-0002-4336-5523
Brannan, Christine https://orcid.org/0000-0002-7177-2396
Gonzalez, Loreto Fernandez https://orcid.org/0000-0001-5026-6438
Inhestern, Johanna https://orcid.org/0000-0003-4613-2810
Pinto, Monica https://orcid.org/0000-0002-0823-4907
Arraras, Juan I. https://orcid.org/0000-0002-4415-2570
Yarom, Noam https://orcid.org/0000-0001-9771-7857
Bonomo, Pierluigi
Baumann, Ingo
Galalae, Razvan https://orcid.org/0000-0001-8800-5460
Nicolatou-Galitis, Ourania https://orcid.org/0000-0001-9036-6329
Kiyota, Naomi https://orcid.org/0000-0001-8021-6116
Raber-Durlacher, Judith https://orcid.org/0000-0003-1500-8390
Salem, Dina https://orcid.org/0000-0001-9281-0999
Fabian, Alexander https://orcid.org/0000-0003-2415-527X
Boehm, Andreas https://orcid.org/0000-0001-9511-9167
Krejovic-Trivic, Sanja
Chie, Wei-Chu https://orcid.org/0000-0001-5584-6554
Taylor, Katherine https://orcid.org/0000-0003-0768-5789
Simon, Christian https://orcid.org/0000-0002-4156-9143
Licitra, Lisa https://orcid.org/0000-0003-0623-4118
Sherman, Allen C. https://orcid.org/0000-0001-5457-1659
,
-
Funding
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (001/2014)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- License Information
-
More Information
Article History
Accepted: 5 July 2021
First Online: 16 July 2021
Declarations
:
: CA, IA, IB, KB, AB, PB, CB, JCS, WC, JR-D, AF, LF-G, AF, RG, EH, BBH, JI, ON-G, DS, MS, AS, KT, IT, SK-T, and NY declare they have no conflicts of interest. NK reports honoraria from ONO PHARMACEUTICAL, Bristol Meyers Squibb, Merck Biopharma, Astra-Zeneca, Merck Sharp & Dohme, Eisai, Bayer and Chugai Pharmaceutical, all outside the submitted work. LL reports grants and personal fees from Astra-Zeneca, BMS, Boehringer-Ingelheim, Debiopharm International SA, Eisai, Merck-Serono, MSD, Novartis, Roche; personal fees from Bayer, Sobi, Ipsen, GSK, Doxa Pharma srl, Incyte Biosciences Italy, Amgen, Nanobiotics; grants from Celgene International, Exelicis, Hofmann-La Roche, IRX Therapeutics, Medpace, Pfizer, all outside the submitted work. HM reports grants from Cancer Research UK, during the conduct of the study; personal fees and other from Warwickshire Head Neck Clinic Ltd, personal fees from Astra-Zeneca, MSD, Sanofi Pasteur, Merck, grants from GSK Biologicals, Sanofi Pasteur, GSK PLC, Astra-Zeneca, non-financial support from Sanofi Pasteur, MSD, Merck, outside the submitted work. He is a National Institute for Health Research (NIHR) Senior Investigator. The views expressed in this article are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care. MP reports personal fees from Meeting&Words, outside the submitted work. CS reports grants from Roche, Intuitive; personal fees from Pizer, Merck, MSD, Seattle Genetics, all outside the submitted work. SS reports personal fees from Lilly, Pfizer, Boehringer-Ingelheim, all outside the submitted work.
: All sites obtained ethical approval in accordance with regional and national requirements. Approval Number from the principal investigator’s institution: 837.281.14 (9520).
: Patients were given time to consider the study and ask any questions before consenting and participating.
: All participants provided written informed consent.
